Press Releases about Ensysce Biosciences, Inc. - Common Stock![]()
Ensysce Biosciences Announces IRB Approval of Key Study Protocol
August 08, 2023
Via ACCESSWIRE
![]() Via ACCESSWIRE
![]() ![]()
Ensysce Biosciences Regains Compliance with Nasdaq
June 13, 2023
Via ACCESSWIRE
![]() ![]() Via ACCESSWIRE
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Ensysce Biosciences Provides Corporate Update
February 23, 2023
Via ACCESSWIRE
![]()
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
February 15, 2023
Via ACCESSWIRE
![]() ![]() ![]() Via ACCESSWIRE
![]() ![]() ![]() ![]() ![]()
Ensysce Biosciences Issues 2023 Shareholder Letter
January 11, 2023
Via ACCESSWIRE
![]() ![]()
Ensysce Biosciences Announces Pricing of $4.1 Million Public Offering
December 07, 2022
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|